In the news

Avitide, Inc., Secures Series A Financing To Commercialize Novel Biopharmaceutical Affinity Purification Technology

Funding From Borealis, SV Life Sciences, Polaris, and OrbiMed Advisors   Lebanon, New Hampshire – March 15,  2013 – Avitide, Inc., a biotech company dedicated to the discovery and development of custom affinity purification solutions for the biopharmaceutical industry, announced the closing of their Series A financing. The Avitide technology is designed to discover and develop affinity purification products that will improve the fundamental timeframes and economics of commercial bioprocessing. The financing was led by Borealis Ventures with participation from SV Life Sciences, Polaris Venture Partners, OrbiMed Advisors, and Angeli Parvi. Managing Partners Phil Ferneau (Borealis Ventures) and Michael Ross (SV…

Read More »